SiriusXT, an Irish technology SME, has announced the world’s first commercial deployment of the SXT-100, the company’s unique table-top soft X-ray microscope with applications in disease research and the drug discovery process. The microscope will be formally unveiled on 7 November at the University College Dublin Conway Institute of Biomolecular and Biomedical Research.
Over 200 health journals across the world have come together to simultaneously publish an editorial on 25 October calling on world leaders and health professionals to recognise that climate change and biodiversity loss are one indivisible crisis and must be tackled together to preserve health and avoid catastrophe.
Researchers at Stockholm University have unveiled the hidden intricacies of how sperm go from passive bystanders to dynamic swimmers. This transformation is a pivotal step in the journey to fertilization, and it hinges on the activation of a unique ion transporter. Their research is published in the journal Nature [1].
Researchers have developed a new way of improving diagnosis of bipolar disorder that uses a simple blood test to identify biomarkers associated with the condition.
The FlowLab Column from Uniqsis is an affordable flow chemistry system designed specifically for high temperature and pressure catalysis applications. At the heart of the FlowLab Column is a HotCoil heated reactor module fitted with a HotColumn adapter to enable operation up to +260 °C (300 °C as an option).
Kivo, the intuitive Document Management Solution for life sciences, has introduced Kivo GO, a unified platform for emerging life sciences teams who need to work together efficiently across all functions while maintaining compliance and security.
HORIBA UK has expanded its clinical chemistry portfolio with the addition of a new test kit for Glucose-6-phosphate dehydrogenase (G6PD) from Pointe Scientific. HORIBA is distributing this cell function assay to the UK market following its acquisition of US-based Pointe Scientific in 2021. Used for the quantitative determination of G6PD enzyme activity in blood, the […]
Sebia, a world leader in multiple myeloma diagnostics and monitoring, has introduced M-inSight its serum-based Minimal Residual Disease (MRD) test for monitoring in multiple myeloma. M-inSight is a Laboratory Developed Test (LDT) being offered by Corgenix, part of the Sebia Group.
ScreenIn3D reports on how their proprietary lab-on-a-chip technology is enabling cancer researchers to miniaturize their testing of biopsy tissue samples across a wide range of modalities and to test both single and combination drug therapies on live tissue samples.
Polpharma Biologics, an international biotech company focused on developing and manufacturing biosimilars, has received approval from the European Commission for Tyruko (natalizumab) as the first and only biosimilar for relapsing forms of multiple sclerosis (MS) in Europe. Tyruko was developed by Polpharma Biologics and will be commercialized by its collaboration partner Sandoz.
Beukenlaan 137
5616 VD Eindhoven
The Netherlands
+31 85064 55 82
info@clinlabint.com
PanGlobal Media is not responsible for any error or omission that might occur in the electronic display of product or company data.
